Literature DB >> 21696238

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Indrani Datta1, Swati Mishra, Lipsa Mohanty, Sunitha Pulikkot, Preeti G Joshi.   

Abstract

BACKGROUND AIMS: Mesenchymal stromal cells (MSC) derived from Wharton's jelly (WJ) of the umbilical cord are increasingly gaining prominence as substitutes for bone marrow (BM) MSC. While MSC isolated from different tissue sources may share common mesenchymal properties, the difference in their plasticity to individual lineages is ill-defined. Thus the focus of this study was to estimate the neuronal plasticity of WJ MSC to the dopaminergic (DA) cell type in comparison with BM MSC.
METHODS: For neuronal differentiation, MSC were exposed to developmentally relevant cues for midbrain DA neurons: sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8), along with basic fibroblast growth factor (bFGF).
RESULTS: Naive MSC from both sources constitutively expressed neuronal markers. Flow cytometry data revealed that the control WJ MSC shared a signature similar to BM MSC for early neuronal markers (nestin, musashi12 and A2B5) and DA-specific markers [tyrosine hydroxylase (TH) and Nuclear Receptor related protein 1 (Nurr1) but differed for mature neuronal proteins [β-tubulin III and microtubule-associated protein 2 (Map2ab)]. Similar populations of cells in both sources of MSC were positive for the SHH receptors [patched (PTCH) and smoothened (SMO)]. In induced BM and WJ MSC, real-time reverse transcriptase (RT)-polymerase chain reaction (PCR) analysis showed similar levels of DA-related transcription factors Nurr1 and Engrailed (En) 1. Immunocytochemical and flow cytometry analysis showed an increase in mature neuronal marker Map2ab. Kv4.2, a K(+) channel marker, was observed only in the induced MSC. Induced MSC also expressed several DA-specific markers, TH, dopamine and cyclic AMP regulated phosphoprotein (DARPP) 32, paired-like homeodomain transcription factor (PitX) 3 and vesicular monoamine transporter (VMAT) 2, in comparable levels between the two sources. The efficiency (c. 65%) of transdifferentiation of WJ MSC to TH-positive cells was similar to that of induced BM MSC. Constitutive and inducible release of dopamine was found to be similar between induced BM and WJ MSC, as measured by dopamine enzyme-linked immunosorbent assay (ELISA). Interestingly, an adenosine triphosphate (ATP)-stimulated change in intracellular Ca(2+) was observed in both control and induced MSC, but only the induced MSC was capable of releasing dopamine.
CONCLUSIONS: Our data demonstrate that MSC from the two different sources respond similarly to inductive cues to differentiate terminally to a DA cell type, and the neuronal plasticity of human WJ MSC is comparable with that of BM MSC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21696238     DOI: 10.3109/14653249.2011.579957

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  25 in total

1.  Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.

Authors:  Indrani Datta; S R Mekha; Alka Kaushal; Kavina Ganapathy; Rema Razdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-29       Impact factor: 3.000

2.  Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential.

Authors:  Marianne Messerli; Anna Wagner; Ruth Sager; Martin Mueller; Marc Baumann; Daniel V Surbek; Andreina Schoeberlein
Journal:  Reprod Sci       Date:  2013-05-13       Impact factor: 3.060

Review 3.  In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources.

Authors:  Ramyani Taran; Murali Krishna Mamidi; Gurbind Singh; Susmita Dutta; Ishwar S Parhar; John P John; Ramesh Bhonde; Rajarshi Pal; Anjan Kumar Das
Journal:  J Biosci       Date:  2014-03       Impact factor: 1.826

4.  Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation.

Authors:  Fábio G Teixeira; Miguel M Carvalho; Andreia Neves-Carvalho; Krishna M Panchalingam; Leo A Behie; Luísa Pinto; Nuno Sousa; António J Salgado
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

5.  Recovery of Human Embryonic Stem Cells-Derived Neural Progenitors Exposed to Hypoxic-Ischemic-Reperfusion Injury by Indirect Exposure to Wharton's Jelly Mesenchymal Stem Cells Through Phosphatidyl-inositol-3-Kinase Pathway.

Authors:  Sowmithra Sowmithra; Nishtha Kusum Jain; Ramesh Bhonde; Indrani Datta
Journal:  Cell Mol Neurobiol       Date:  2020-11-18       Impact factor: 5.046

Review 6.  Cell replacement therapy is the remedial solution for treating Parkinson's disease.

Authors:  Venkatesan Dhivya; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-06-30

7.  Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study.

Authors:  N K Venkataramana; Rakhi Pal; Shailesh A V Rao; Arun L Naik; Majahar Jan; Rahul Nair; C C Sanjeev; Ravindra B Kamble; D P Murthy; Krishna Chaitanya
Journal:  Stem Cells Int       Date:  2012-03-13       Impact factor: 5.443

8.  Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy.

Authors:  Masaaki Kitada; Mari Dezawa
Journal:  Parkinsons Dis       Date:  2012-02-28

9.  Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold.

Authors:  Seyed Mojtaba Hosseini; Attiyeh Vasaghi; Newsha Nakhlparvar; Reza Roshanravan; Tahereh Talaei-Khozani; Zahra Razi
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

10.  Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.

Authors:  Min Yan; Maosheng Sun; Yan Zhou; Wanpu Wang; Zhanlong He; Donghong Tang; Shuaiyao Lu; Xiaonan Wang; Song Li; Wenju Wang; Hongjun Li
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.